Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.

American journal of respiratory and critical care medicine·2026
Same author

COPD Trial Evidence Comes From a Narrow Slice of the World: A Population Representativeness Analysis.

Chest·2026
Same author

Prevalence of respiratory viruses in stable and acute asthma: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Adjuvanted-RSVPreF3 vaccine uptake and effectiveness in individuals with COPD: a nationwide Danish cohort study.

Expert review of vaccines·2026
Same author

Plasma growth differentiation factor-15 is associated with cardiovascular events in patients hospitalized for acute exacerbation of COPD.

Scientific reports·2026
Same author

Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial.

Thorax·2025
Same journal

Impact of Therapeutic Hypothermia on Oxygen Demand and Respiratory Function in Post-Cardiac Arrest Patients: A Retrospective Cohort Study.

Respiratory medicine·2026
Same journal

The longitudinal decrease in exercise tolerance and disease progression in mild-to-moderate COPD.

Respiratory medicine·2026
Same journal

The implications of adopting the race-neutral spirometry equations in the detection of airway obstruction in Chilean children with asthma.

Respiratory medicine·2026
Same journal

Long-term outcomes of home mechanical ventilation in Duchenne Muscular Dystrophy - an observational study.

Respiratory medicine·2026
Same journal

CT-derived vascular parameters and bone mineral density in adults with cystic fibrosis.

Respiratory medicine·2026
Same journal

Effects of Integrated Inspiratory-Expiratory Muscle Training Within Hybrid Cardiac Rehabilitation Following Cardiac Surgery: A Randomized Controlled Study.

Respiratory medicine·2026
See all related articles

Related Experiment Videos

Improved survival prediction from lung function data in a large population sample.

Martin R Miller1, Ole F Pedersen, Peter Lange

  • 1Department of Medicine, University Hospital Birmingham NHS Trust, Selly Oak Hospital, UK. martin.miller@uhb.nhs.uk

Respiratory Medicine
|November 11, 2008
PubMed
Summary
This summary is machine-generated.

This study found that expressing lung function using FEV(1)/ht(2) is superior to percent predicted (FEV(1)PP) for predicting mortality. This improved method better identifies individuals at higher risk of death from all causes and lung disease.

Related Experiment Videos

Area of Science:

  • Pulmonary Medicine
  • Epidemiology
  • Biostatistics

Background:

  • Lung function impairment is commonly assessed using percent predicted forced expiratory volume in 1s (FEV(1)PP).
  • FEV(1)PP retains age, height, and sex biases, potentially limiting its accuracy in predicting mortality.
  • Alternative methods for expressing FEV(1) may offer improved prognostic value.

Purpose of the Study:

  • To evaluate alternative methods of expressing FEV(1) for predicting all-cause and airway-related lung disease mortality.
  • To compare the predictive performance of FEV(1)/ht(2) against FEV(1)PP and FEV(1)SR.

Main Methods:

  • Utilized data from the Copenhagen City Heart Study, including 13,900 subjects with 25 years of follow-up.
  • Employed Cox regression models to assess predictors of survival.
  • Compared FEV(1) expressed as raw data, FEV(1)/ht(n), FEV(1)PP, and FEV(1)SR.

Main Results:

  • Quintiles of FEV(1)/ht(2) demonstrated superior prediction of all-cause mortality compared to FEV(1)PP and FEV(1)SR in multivariate models.
  • The hazard ratio for the worst quintile of FEV(1)/ht(2) for all-cause mortality was 2.8, versus 2.0 for FEV(1)PP.
  • Categorized FEV(1) impairment showed significantly higher hazard ratios for all-cause (10 vs. 5) and airway disease mortality (2044 vs. 194) with FEV(1)/ht(2) compared to FEV(1)PP.

Conclusions:

  • FEV(1)/ht(2) is a more effective method than FEV(1)PP for predicting survival in a general population.
  • This height-standardized expression of FEV(1) impairment better reflects subsequent mortality risk.
  • The findings suggest a revised approach to assessing lung function for prognostic purposes.